- Home
- NERV vs OSRH Comparison
NERV vs OSRH Comparison
Compare NERV & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- OSRH
- Stock Information
- Founded
- NERV 2007
- OSRH N/A
- Country
- NERV United States
- OSRH United States
- Employees
- NERV N/A
- OSRH N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- OSRH
- Sector
- NERV Health Care
- OSRH
- Exchange
- NERV Nasdaq
- OSRH Nasdaq
- Market Cap
- NERV 12.0M
- OSRH 11.1M
- IPO Year
- NERV 2014
- OSRH N/A
- Fundamental
- Price
- NERV $2.35
- OSRH $0.58
- Analyst Decision
- NERV Hold
- OSRH
- Analyst Count
- NERV 1
- OSRH 0
- Target Price
- NERV $5.00
- OSRH N/A
- AVG Volume (30 Days)
- NERV 41.4K
- OSRH 13.8M
- Earning Date
- NERV 11-04-2025
- OSRH 08-14-2025
- Dividend Yield
- NERV N/A
- OSRH N/A
- EPS Growth
- NERV N/A
- OSRH N/A
- EPS
- NERV 1.48
- OSRH N/A
- Revenue
- NERV N/A
- OSRH $104,735.00
- Revenue This Year
- NERV N/A
- OSRH N/A
- Revenue Next Year
- NERV N/A
- OSRH N/A
- P/E Ratio
- NERV $1.58
- OSRH N/A
- Revenue Growth
- NERV N/A
- OSRH N/A
- 52 Week Low
- NERV $1.15
- OSRH $0.45
- 52 Week High
- NERV $3.00
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- NERV 59.22
- OSRH 41.12
- Support Level
- NERV $2.26
- OSRH $0.74
- Resistance Level
- NERV $2.47
- OSRH $1.24
- Average True Range (ATR)
- NERV 0.15
- OSRH 0.11
- MACD
- NERV -0.01
- OSRH 0.01
- Stochastic Oscillator
- NERV 36.71
- OSRH 15.50
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.